Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05162443 |
Title | Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation |
Recruitment | Approved for marketing |
Gender | both |
Phase | Expanded access |
Variant Requirements | No |
Sponsors | Mirati Therapeutics Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
California Pacific Medical Center | San Francisco | California | 94115 | United States | Details | |
Providence Medical Group Santa Rosa - Cancer Center | Santa Rosa | California | 95403 | United States | Details | |
Hartford Hospital | Hartford | Connecticut | 06106 | United States | Details | |
Piedmont Cancer Institute | Atlanta | Georgia | 30318 | United States | Details | |
Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | United States | Details | |
Renown Health | Reno | Nevada | 89502 | United States | Details | |
Lehigh Valley Cancer Institute | Allentown | Pennsylvania | 18103 | United States | Details | |
Lumi Research | Kingwood | Texas | 77339 | United States | Details | |
Virginia Cancer Institute | Richmond | Virginia | 23230 | United States | Details | |
Seattle Integrative Cancer Center | Renton | Washington | 98057 | United States | Details | |
Swedish Cancer Institute | Seattle | Washington | 98104 | United States | Details |